Guardant Health grows with Shield blood CRC screening, Quest deal, 50M reach, 335% surge, and FY25 revenue $981M up 33%. Read ...

Colorectal cancer was once considered primarily a disease of aging. But rates are now on the rise among younger adults. Since 2011, colon cancer rates among people younger than 50 have increased by ...

Colon capsule endoscopy (CCE) represents a significant advance in colorectal cancer screening, offering a minimally invasive and patient‐friendly alternative to conventional colonoscopy. By using an ...

Two new studies report worse colorectal cancer survival among patients with lower socioeconomic status, adding weight to a ...

According to a 2025 survey conducted by the Prevent Cancer Foundation, only 51% of U.S. adults 21 and older say they have had ...

Rhythm Biosciences Ltd. launched a new genetype colorectal cancer risk assessment clinical test that incorporates clinical ...

Disparities in demographics, clinical features, and outcomes of early-onset colon cancer in the US. Clinical outcome, treatment modalities and overall survival in microsatellite stable and unstable ...

Dr. Bethany Malone has treated a lot of colorectal cancer patients. The youngest, not counting those with genetic conditions, ...

Modeling suggests Medicaid eligibility restrictions could lead to 7.5 million coverage losses, over 1 million missed breast, ...

According to Cologuard, made by Wisconsin-based Exact Sciences, there are three primary reasons why you may receive a testing kit in the mail without ordering it yourself: your doctor or health care ...